0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
164 Ansichten12 Seiten
Generic name Simvastat in Brand Name Vidastal Classification Mechanis m of action Does not reduce basal plasma cortisol or testostero ne levels or impair renal reserve. Use if pregnant, planning to become pregnant, or while breasfeeding.
Generic name Simvastat in Brand Name Vidastal Classification Mechanis m of action Does not reduce basal plasma cortisol or testostero ne levels or impair renal reserve. Use if pregnant, planning to become pregnant, or while breasfeeding.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Generic name Simvastat in Brand Name Vidastal Classification Mechanis m of action Does not reduce basal plasma cortisol or testostero ne levels or impair renal reserve. Use if pregnant, planning to become pregnant, or while breasfeeding.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Generic Brand Classification Mechanis Contraindicati Side How Dosage Nursing
name Name m of ons effects supplied and responsibilities action frequenc y Simvastat Vidastal Antihyperlipide Does not Use if Tablet: Give 1 Before: in mic, HMG-CoA reduce pregnant, 5 mg, tab 1. List all reductase basal planning to 20 mg, orally medicatio inhibitor. plasma become 40 mg, once a ns cortisol or pregnant, or 80 mg. day. prescribed testostero while to ensure ne levels breasfeeding. non or impair interact renal unfavorabl reserve. y. (PDR, 2. Assess spratto, level of 2006 adherence edition, to weight pg. 1189). reduction, exercise, & cholestero l lowering diet & bp. 3. Check for allergic reactions. During: 1. May give without regard to meals. 2. A low- cholestero l diet must be followed during therapy. 3. Make sure the patient has taken the right medicatio n. After: 1. Note indication for therapy plaque stability/el evated TG/LDL cholestero l in CAD. 2. Monitor CBC, cholestero l profile, liver, CPK & renal function studies. 3. Report any S&S of infection, unexplain ed muscle pain, tendernes s, surgery,tr auma/ metabolic disorders.
Generic Brand Classificati Mechanis Contraindicati Side How Dosage Nursing
name Name on m of ons effects supplied and responsibilities action frequency Pantopraz Proton Proton 1 tab Before: ole sodium pump pump orally 1. List inhibitor inhibitor before drugs that breakfast prescribe suppresse once a d to s the final day. ensure step in none gastric require production acidity by forming for a cavalent medicati bond to on. two sites 2. Do not of the H+/ freeze K+- reconstit ATPase uted enzyme drug. system at 3. Check for the allergic secretory reactions surface of . the gastric During: parietal 1. Do not cell. split, Results in crush/ inhibition chew the of both delayed basal and release stimulated tablets; gastric swallow secretion the regardless whole. of the 2. May take stimulus. with or Duration without greater food in than 24 hr the due to stomach. binding to 3. Make ATPase. sure the Gastrin patient levels swallowe increase. d the Absorption medicati begins on. only after After: the tablet 1. Instruct leaves the the stomach patient although it to avoid occurs alcohol, rapidly. aspirin/ Absorption NSAID’s is not & food affected that may by cause GI antacids, irritation. although 2. Report food may abdomin delay al pain, absorption evidence up to 2 hr of or longer. bleeding Extensivel & any y unusual metaboliz side ed in the effects, liver by worsenin the CYP g of S&S/ system. lack of Excreted response in both . the urine 3. Keep F/U (71%) and appointm feces ents. (18%). ( PDR, spratto, 2006 edition, pg. 996). Generic Brand Classificati Mechanis Contraindicati Side How Dosage Nursing name Name on m of ons effects supplied and responsibilities action frequency Metoprolo Give one Before: l tartrate fourth 1. Monitor tab. CXR, CBC, Orally liver/renal twice a function day. studies, ECG, echocardi ogram, EF & VS. 2. For CHF, do not increase dose until symptoms of worsening have been stabilized. 3. Check for allergic reactions. During: 1. Make sure the patient swallowed the tablet as prescribe d. 2. Make sure you give the right patient & right medicatio n. 3. Provide the patient needs. After: 1. Advise patient to make position changes slowly to minimize orthostati c hypotensi on. 2. Caution patient that this medicatio n may increase sensitivity to cold. 3. Advise patient to carry identificat ion describing disease process & medicatio n regimen at all times.
Generic Brand Classificati Mechanis Contraindicati Side How Dosage Nursing
name Name on m of ons effects supplied and responsibilities action frequenc y Levofloxac Give one Before: in tablet by 1.Assess for any mouth seizure history/ once a CNS disorders; day. may preclude therapy. Obtain baseline cultures, CBC, BS, liver & renal function studies. Thaw frozen solution at room temperature/ in a refrigerator. During: 1. Administer on an empty stomach, 1 hr. before/ 2 hr. after meals with full glass of water. 2. If gastric irritation occurs, may be administere d with meals. 3. Milk & yogurt decrease the absorption. After: 1. Encourage patient to maintain a fluid intake. 2. Instruct patient to take medication as directed & to finish drug completely. 3. Advise patient that frequent mouth wash & oral hygiene may minimize dry mouth.
Generic Brand Classificati Mechanis Contraindicati Side How Dosage Nursing
name Name on m of ons effects supplied and responsibilities action frequency Cilostazol Give 1 Before: tablet 1. Do not orally expose after premixed lunch single-dose once a product to day. excessive heat; store at 15-30 C. 2. List drugs prescribed to ensure none interact unfavorably . 3. Assess location, characterist ics, extent of abdominal pain; note blood in emesis, stool/ gastric aspirate. During: 1. Administer PO medication with meals & with a snack at bedtime. 2. In renal dysfunction , a dose of 300 mg PO/ IV g 12 hr. may be necessary. 3. For IM use, give undiluted. After: 1. Note general client condition. 2. Document indications for therapy, type/ onset of symptoms & anticipated. 3. Monitor V/S & I&O.